193 related articles for article (PubMed ID: 29741882)
1. Identification and Structure-Activity Relationship of HDAC6 Zinc-Finger Ubiquitin Binding Domain Inhibitors.
Ferreira de Freitas R; Harding RJ; Franzoni I; Ravichandran M; Mann MK; Ouyang H; Lautens M; Santhakumar V; Arrowsmith CH; Schapira M
J Med Chem; 2018 May; 61(10):4517-4527. PubMed ID: 29741882
[TBL] [Abstract][Full Text] [Related]
2. Small Molecule Antagonists of the Interaction between the Histone Deacetylase 6 Zinc-Finger Domain and Ubiquitin.
Harding RJ; Ferreira de Freitas R; Collins P; Franzoni I; Ravichandran M; Ouyang H; Juarez-Ornelas KA; Lautens M; Schapira M; von Delft F; Santhakumar V; Arrowsmith CH
J Med Chem; 2017 Nov; 60(21):9090-9096. PubMed ID: 29019676
[TBL] [Abstract][Full Text] [Related]
3. Discovery and Characterization of a Chemical Probe Targeting the Zinc-Finger Ubiquitin-Binding Domain of HDAC6.
Harding RJ; Franzoni I; Mann MK; Szewczyk MM; Mirabi B; Ferreira de Freitas R; Owens DDG; Ackloo S; Scheremetjew A; Juarez-Ornelas KA; Sanichar R; Baker RJ; Dank C; Brown PJ; Barsyte-Lovejoy D; Santhakumar V; Schapira M; Lautens M; Arrowsmith CH
J Med Chem; 2023 Aug; 66(15):10273-10288. PubMed ID: 37499118
[TBL] [Abstract][Full Text] [Related]
4. HDAC6 ZnF UBP as the Modifier of Tau Structure and Function.
Balmik AA; Chidambaram H; Dangi A; Marelli UK; Chinnathambi S
Biochemistry; 2020 Dec; 59(48):4546-4562. PubMed ID: 33237772
[TBL] [Abstract][Full Text] [Related]
5. Binding of inhibitors to active-site mutants of CD1, the enigmatic catalytic domain of histone deacetylase 6.
Osko JD; Christianson DW
Acta Crystallogr F Struct Biol Commun; 2020 Sep; 76(Pt 9):428-437. PubMed ID: 32880591
[TBL] [Abstract][Full Text] [Related]
6. Carboxylic acid derivatives display potential selectivity for human histone deacetylase 6: Structure-based virtual screening, molecular docking and dynamics simulation studies.
Uba AI; Yelekçi K
Comput Biol Chem; 2018 Aug; 75():131-142. PubMed ID: 29859380
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics of zinc-finger ubiquitin binding domains: a comparative study of histone deacetylase 6 and ubiquitin-specific protease 5.
Dos Santos Passos C; Simões-Pires CA; Carrupt PA; Nurisso A
J Biomol Struct Dyn; 2016 Dec; 34(12):2581-2598. PubMed ID: 26619262
[TBL] [Abstract][Full Text] [Related]
8. Purification of Unanchored Polyubiquitin Chains from Influenza Virions.
Miyake Y; Matthias P; Yamauchi Y
Methods Mol Biol; 2018; 1836():329-342. PubMed ID: 30151581
[TBL] [Abstract][Full Text] [Related]
9. Identification of Novel Histone Deacetylase 6-Selective Inhibitors Bearing 3,3,3-Trifluorolactic Amide (TFLAM) Motif as a Zinc Binding Group.
Kurohara T; Tanaka K; Takahashi D; Ueda S; Yamashita Y; Takada Y; Takeshima H; Yu S; Itoh Y; Hase K; Suzuki T
Chembiochem; 2021 Nov; 22(22):3158-3163. PubMed ID: 34224197
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group.
Linciano P; Pinzi L; Belluti S; Chianese U; Benedetti R; Moi D; Altucci L; Franchini S; Imbriano C; Sorbi C; Rastelli G
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):2080-2086. PubMed ID: 34583596
[TBL] [Abstract][Full Text] [Related]
11. Discovery of the First-in-Class Dual Histone Deacetylase-Proteasome Inhibitor.
Bhatia S; Krieger V; Groll M; Osko JD; Reßing N; Ahlert H; Borkhardt A; Kurz T; Christianson DW; Hauer J; Hansen FK
J Med Chem; 2018 Nov; 61(22):10299-10309. PubMed ID: 30365892
[TBL] [Abstract][Full Text] [Related]
12. Fragment-Based Drug Design of Selective HDAC6 Inhibitors.
Ruzic D; Djokovic N; Nikolic K
Methods Mol Biol; 2021; 2266():155-170. PubMed ID: 33759126
[TBL] [Abstract][Full Text] [Related]
13. Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors.
Porter NJ; Mahendran A; Breslow R; Christianson DW
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):13459-13464. PubMed ID: 29203661
[TBL] [Abstract][Full Text] [Related]
14. Discovery of specific HDAC6 inhibitor with anti-metastatic effects in pancreatic cancer cells through virtual screening and biological evaluation.
Song H; Niu X; Quan J; Li Y; Yuan L; Wang J; Ma C; Ma E
Bioorg Chem; 2020 Apr; 97():103679. PubMed ID: 32120077
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors.
Vögerl K; Ong N; Senger J; Herp D; Schmidtkunz K; Marek M; Müller M; Bartel K; Shaik TB; Porter NJ; Robaa D; Christianson DW; Romier C; Sippl W; Jung M; Bracher F
J Med Chem; 2019 Feb; 62(3):1138-1166. PubMed ID: 30645113
[TBL] [Abstract][Full Text] [Related]
16. Methods for the expression, purification, and crystallization of histone deacetylase 6-inhibitor complexes.
Osko JD; Christianson DW
Methods Enzymol; 2019; 626():447-474. PubMed ID: 31606087
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Small Molecule Antagonists of the USP5 Zinc Finger Ubiquitin-Binding Domain.
Mann MK; Franzoni I; de Freitas RF; Tempel W; Houliston S; Smith L; Vedadi M; Arrowsmith CH; Harding RJ; Schapira M
J Med Chem; 2019 Nov; 62(22):10144-10155. PubMed ID: 31663737
[TBL] [Abstract][Full Text] [Related]
18. Combined Ligand and Fragment-based Drug Design of Selective Histone Deacetylase - 6 Inhibitors.
Ruzic D; Petkovic M; Agbaba D; Ganesan A; Nikolic K
Mol Inform; 2019 May; 38(5):e1800083. PubMed ID: 30632697
[TBL] [Abstract][Full Text] [Related]
19. Structure-Based Drug Designing Recommends HDAC6 Inhibitors To Attenuate Microtubule-Associated Tau-Pathogenesis.
Zeb A; Park C; Rampogu S; Son M; Lee G; Lee KW
ACS Chem Neurosci; 2019 Mar; 10(3):1326-1335. PubMed ID: 30407786
[TBL] [Abstract][Full Text] [Related]
20. Molecular docking-based virtual drug screening revealing an oxofluorenyl benzamide and a bromonaphthalene sulfonamido hydroxybenzoic acid as HDAC6 inhibitors with cytotoxicity against leukemia cells.
Dawood M; Elbadawi M; Böckers M; Bringmann G; Efferth T
Biomed Pharmacother; 2020 Sep; 129():110454. PubMed ID: 32768947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
